Medical News

RSS

COPD still affects treatment received after heart attack

Patients with chronic obstructive pulmonary disease receive less aggressive treatment after hospitalization for acute myocardial infarction than those without the lung condition, US study results show.

10 Jul 2012

Relaxin key to improved stroke rehabilitation outcomes

Treatment with the reproductive hormone relaxin during physical rehabilitative therapy appears to improve long-term outcomes in stroke patients over rehabilitative therapy alone, say researchers.

10 Jul 2012

Shear forces cause vessel identity crisis

Lymphatic vessels exposed to fast-flowing blood take on characteristics associated with blood vessels, report researchers.

10 Jul 2012

Physicians comply with patient wishes over severe fetal anomalies

Study results indicate that physicians respect patient autonomy in the case of uniformly and commonly lethal fetal anomalies, respecting the wishes of parents in how to manage the pregnancy.

10 Jul 2012

Satisfaction with home-whitening lasts

Patient satisfaction with the shade of their teeth after nightguard vital bleaching could last up to 12 years on average, report US researchers.

10 Jul 2012

Developmental delay should not prevent implants for deaf children

Children should not be excluded from having cochlear implantation just because they have impaired cognitive development, say researchers.

10 Jul 2012

Emotion awareness linked to social functioning in schizophrenia

Emotion awareness and regulation deficits are significantly associated with reduced social functioning in patients with schizophrenia, research shows.

10 Jul 2012

Specific cytokine levels altered in BD patients

Levels of certain cytokines differ between bipolar disorder patients and mentally healthy individuals, as well as between manic and euthymic patients with the mood disorder, results from a systematic review and meta-analysis show.

10 Jul 2012

$Vertebral fracture more common among Chinese women than men$

Vertebral fracture more common among Chinese women than men

Vertebral deformities occur at a similar rate among Chinese men and women aged 65 years or older, research findings show.

10 Jul 2012

‘Sexting’ reflects sexual behavior in adolescents

Research suggests that the prevalence of teenage “sexting,” where adolescents send nude pictures of themselves or sexually explicit text messages by SMS, is on the increase and is a marker of risky sexual behavior.

10 Jul 2012

Jehovah’s Witnesses’ beliefs do not necessarily put them at risk

Jehovah’s Witnesses do not have a significantly increased risk for complications or long-term mortality after cardiac surgery, researchers say.

10 Jul 2012

Salt content in UK takeaway meals ‘alarmingly high’

The level of salt in hot takeaway meals from small independent outlets in the UK should be reduced to minimize adverse health consequences, say researchers who found that levels were disturbingly high.

10 Jul 2012

Scientists identify novel strategy to target Taspase1 enzyme

Scientists at the University Medical Center of Johannes Gutenberg University Mainz in Germany identified a novel strategy to target the oncologically relevant protein-cleaving enzyme Taspase1.

10 Jul 2012

STAT Ticket, Winola Lake partner to provide unique hospital issue reporting system

Winola Lake has partnered with STAT Ticket, a Boston, Massachusetts based software company, to provide a unique hospital issue reporting system.

10 Jul 2012

Bankers Life and Casualty introduces new life and health insurance product

Bankers Life and Casualty Company today announced a new addition to its portfolio of life and health insurance products, Critical Benefit.

10 Jul 2012

ImmunoCellular receives Japanese patent allowance for brain cancer technology

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of a Japanese patent relating to a technology for the treatment of brain cancer for which the Company holds an exclusive, worldwide license.

10 Jul 2012

FDA acknowledges receipt of resubmission of Human Genome Sciences’ raxibacumab BLA

Human Genome Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for raxibacumab, a treatment for inhalational anthrax, and has established December 15, 2012 as the Prescription Drug User Fee Act (PDUFA) action date.

10 Jul 2012